GLOBAL INDUSTRY INSIGHT: Dermatology Drug Market Trends, Size, Share, Development, Growth and

Demand Forecast to 2020

Dermatology Drug Market Size, Share, Development, Growth and

Demand Forecast to 2020

The increasing prevalence of skin diseases and growing aging population around the world are the

predominant growth drivers for the global dermatology drug market. Acne, psoriasis, and

dermatitis are some common skin diseases. Acne is the most common dermatological condition,

which is caused by clogging of hair follicles by sebum, dirt, and dead skin cells. Acne affects

majority of the world population and leads to scaring. According to the American Academy of

Dermatology, one of the largest organizations of dermatologists in the world, approximately 85%

Americans suffer from acne at some phase in their lives.

Explore more or request TOC on Global Dermatology Drug Market at:

https://www.psmarketresearch.com/market-analysis/dermatology-drug-market

Additionally, the increasing disposable income, strong drug pipeline, and initiatives taken by

various government associations to raise awareness about various types of skin diseases and its

management are also driving the growth of the global market. The increasing numbers of mergers

and acquisitions is one of the major trends observed in the market.

Dermatology is a branch of medicine focused on the diagnosis and treatment of diseases of the

skin, nails, hair, and mucous membranes. The major skin diseases include dermatitis, acne,

psoriasis, eczema, skin infections, and skin cancer. Hair loss is the most common hair disorders

around the world. Bacterial and fungal infections in nails, ingrown nails, tumors and warts are

some common nail disorders. In order to treat the skin, nail and hair diseases, dermatologists

recommend dermatology drugs for their management.

The stringent regulation for the approval of dermatology drugs is restraining the growth of the

global market. Moreover, the lack of awareness about the innovative applications is also hindering

the growth of the global dermatology drug market, especially in the developing countries, such as

India and China.

North America and Europe are the major markets, due to increasing prevalence of skin diseases,

and increasing awareness about potential applications of dermatology drugs in the regions. The

U.S., followed by Canada, is the largest market for dermatology drug in North America. Whereas,

the U.K. Germany, and France are some of the major countries holding significant share in the

European market.

Download TOC at: https://www.psmarketresearch.com/market-analysis/dermatology-drug-

market/toc-sample

© P&S Market Research. All rights reserved 2

Dermatology Drug Market Size, Share, Development, Growth and

Demand Forecast to 2020

The Asian market is growing with a significant rate, owing to increasing prevalence of skin

diseases, growing geriatric population, and increasing healthcare spending in the region. In

addition, initiatives taken by various government associations to raise awareness about

dermatological problems and its management are also supporting the growth of the Asian

dermatology drug market. The countries, such as India, Japan and China are the major markets in

the region.

Apart from these regions, Latin America is another important market for dermatology drug. This is

due to the increasing R&D investments in the manufacturing of dermatology drugs in low

manufacturing cost regions, including Latin America. Brazil holds the largest share in the Latin

American market, due to the increasing prevalence of skin diseases and growing awareness about

dermatological problems and its management in the country.

Browse related market research at: https://www.psmarketresearch.com/industry-

report/healthcare

Some of the major players operating in the global dermatology drug market include Pierre Fabre,

Merz Pharma, Merck & Co. Inc, Biofrontera AG, Hill Dermaceuticals Inc., Derma Sciences, Almirall,

S.A, Novartis Inc., Stiefel Laboratories, Inc., Valeant Pharmaceuticals International Inc., Galderma,

Bayer AG, and Allergan Inc.

Dermatology Drug Market Segmentation

By Dermatological Disease

Acne (Acne Vulgaris) Dermatitis Psoriasis Skin Cancer Skin Infections Rosacea Alopecia

By Drug Classification

Over-The-Counter Prescription-Based

© P&S Market Research. All rights reserved 3

Dermatology Drug Market Size, Share, Development, Growth and

Demand Forecast to 2020

By Brand

Humira Stelara Enbrel Cubicin Zyvox Solodyn Aczone Protopic Elidel Others

By Geography

North America o U.S. o Canada

Europe o Germany o France o U.K. o Spain o Italy

Asia o Japan o China o India

Latin America o Brazil

Rest of the World

About P&S Market Research

P&S Market Research is a global market research and consulting company. We provide market research reports,

industry reports, business intelligence and research based consulting services across a range of industries.

© P&S Market Research. All rights reserved 4

Dermatology Drug Market Size, Share, Development, Growth and

Demand Forecast to 2020

With the help of our professional corporate relations with various companies, our market research offers the most

accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned

domain to substantiate every single data presented in our publication. Our research assists our client in identifying

new and different windows of opportunity and frame informed and customized strategies for expansion in different

regions.

Contact:

Deep

Assistant – Client Partner

347, 5th Ave. #1402

New York City, NY - 10016

US/ Canada Toll-Free: 1-888-778-7886

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

© P&S Market Research. All rights reserved 5